Status not kept up to date
Clinical Study for Evaluating the Clinical Safety and Effectiveness of the Automated Robotic Robot, Revo-i Surgical Robot System (Model MSR-5100), Used for General Endoscopic Surgery.
NCT04095312 · Yonsei University · Updated 30 Sept 2019
- What is being tested
- Revo-i robotic surgery system (Model MSR-5100); Revo-i robotic surgery system (Model MSR-5100); Revo-i robotic surgery system (Model MSR-5100)
- For
- Periampullary Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 19 years and older. About 33 people. The full rules are on the registry page.
- Where
- South Korea
- When
- Starts or started 17 Sept 2019, ends April 2020. Registered 19 Sept 2019.
- Results
- None posted yet.
In the researchers' words
This study is based on the ergonomic features of the most common surgical procedures, which require advanced techniques and relatively difficult operations, such as pancreatobiliary surgery, prostatectomy, nephrectomy, colon and rectal resection. This study id designed to verify the clinical safety and effectiveness of 'Revo-i Surgical Robot System (Model MSR-5100), developed by Mirae Company to overcome the limitations of general laparoscopic surgery.
Sites
- Department of Surgery, Yonsei University College of MedicineSeoul, South Korea